Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

Stay updated on the latest analyst actions and market trends with this financial article covering upgrades and downgrades for ...

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA) CHMP for use in individuals aged six months and older.

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...

Recently BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry upside down. BioNTech stock has climbed 26% over four days as the ...

Sunday's matchup in New Orleans could serve as a confidence-infusing springboard for the Eagles defense -- or, it could deepen doubts. Philadelphia Phillies (92-62, first in the NL East) vs. New ...

The winter season ushers in a new globally spreading COVID-19 variant called XEC, a mix of KS.1.1 and KP.3.3, both from the ...

Copyright: © 2024 The Author(s). Published by Elsevier Ltd. We recorded activity, effort, and severity of 8 core symptoms every 3 h for up to 24 days, in cohorts ...